XR8-69

CAT: 0013-GTR19185642-01Size: 25 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19185642-01Size:25 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

XR8-69 is a small-molecule inhibitor targeting the SARS-CoV-2 papain-like protease (PLpro), exhibiting low micromolar antiviral activity in infected human cell cultures. This compound is a useful research tool for studying coronavirus replication and the potential of host-directed antiviral strategies in vitro.

Field of Research

Infectious Disease & Virology

Molecular Formula

C26H30N4O2S

Molecular Weight

462.61

Storage Conditions

-20°C

Notes

For research use only.

Related Products

Catalog	Name
GTR19185209-01	XR8-89
GTR19249254-01	NLRP3-IN-69
GTR19235167-01	HSD17B13-IN-69
GTR19274735-01	HDAC6-IN-69
GTR19168470-01	GeA-69
GTR18026995	69 Antibody
GTR19237956-01	α-Glucosidase-IN-69
GTR19217827-01	ASC-69
GTR19223920-01	ARD-69
GTR19212350-01	EGFR-IN-69

Alternative Products

Catalog	Name
T62928-01	XR8-69
MBS5806113	XR8-89
MBS131552	MX69 (MX 69; MX-69)
066-79	HSM1 (28-69) / EMC10 (28-69) / INM02 (28-69) (Human)
066-81	HSM1 (28-69) / EMC10 (28-69) / INM02 (28-69) (Mouse)
T89386-01	α-Glucosidase-IN-69
T30123-01	ARD-69
T73153-01	EGFR-IN-69
HY-161229	HSD17B13-IN-69
T28446-01	PQ-69

XR8-69

Related Products

Alternative Products

Popular Products